Bioaffinity Technologies Inc (BIAF)

Mar 13, 2025

Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer - Joplin Globe

Mar 13, 2025

Mar 13, 2025

Revolutionary Lung Cancer Test Saves $895M: Doctor's Case Study Reveals Game-Changing Results - StockTitan

Mar 13, 2025

Mar 07, 2025

SA biotech plans big cuts to grow core company - The Business Journals

Mar 07, 2025

Mar 06, 2025

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth - 01Net

Mar 06, 2025

Mar 06, 2025

bioAffinity announces cost cuts to boost CyPath Lung sales - Investing.com India

Mar 06, 2025

Mar 06, 2025

BioAffinity accelerates CyPath Lung amid $4M in annual cost savings at PPLS - TipRanks

Mar 06, 2025

Mar 06, 2025

Can bioAffinity's $4M Cost-Cutting Plan Transform Its Cancer Detection Business? - StockTitan

Mar 06, 2025

Mar 02, 2025

bioAffinity Technologies, Inc. (NASDAQ:BIAF) Sees Large Drop in Short Interest - Defense World

Mar 02, 2025

Feb 26, 2025

bioAffinity stock hits 52-week low at $0.55 amid market challenges - Investing.com Canada

Feb 26, 2025

Feb 26, 2025

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million - 01Net

Feb 26, 2025

Feb 26, 2025

BioAffinity Technologies Raises $1.4 Million After Warrant Exercise -February 26, 2025 at 12:59 pm EST - Marketscreener.com

Feb 26, 2025

Feb 26, 2025

How Will bioAffinity's $1.4M Capital Raise Impact Existing Shareholders? - StockTitan

Feb 26, 2025

Feb 26, 2025

bioAffinity's $1.4M Cash Injection Comes With 61% Warrant DiscountWhat's the Real Cost? - StockTitan

Feb 26, 2025

Feb 25, 2025

WallachBeth Capital Announces bioAffinity Technologies Warrant I - GuruFocus.com

Feb 25, 2025

Feb 25, 2025

How bioAffinity's $1.4M Warrant Deal Affects Shareholder Value: Dilution vs. Cash Injection - StockTitan

Feb 25, 2025

Feb 25, 2025

bioAffinity's $1.4M Cash Infusion Comes at a Cost: Warrant Price Slashed by 61% - StockTitan

Feb 25, 2025

Feb 25, 2025

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million - Nasdaq

Feb 25, 2025

Feb 13, 2025

Early lung cancer diagnosis saves 52-year-old Indian man’s life - Mugglehead

Feb 13, 2025

Feb 09, 2025

Zacks Initiates Coverage of bioAffinity With Neutral Recommendation - MSN

Feb 09, 2025

Feb 07, 2025

bioAffinity Technologies faces Nasdaq delisting over price - MSN

Feb 07, 2025

Feb 07, 2025

bioAffinity Technologies faces Nasdaq delisting over price By Investing.com - Investing.com Nigeria

Feb 07, 2025

Feb 07, 2025

British scientists develop lung cancer blood test that gives results in 40 minutes - Mugglehead

Feb 07, 2025

Feb 06, 2025

The Zacks Analyst Blog Highlights Amazon, Bank of America, Caterpillar, NVE and bioAffinity - Nasdaq

Feb 06, 2025

Feb 05, 2025

Top Research Reports for Amazon.com, Bank of America & Caterpillar - Nasdaq

Feb 05, 2025

Feb 05, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 16.7% – Here’s Why - Defense World

Feb 05, 2025

Jan 30, 2025

Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire

Jan 30, 2025

Jan 30, 2025

Press Telegram - Financial Content

Jan 30, 2025

Jan 27, 2025

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 27, 2025

Jan 24, 2025

Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire

Jan 24, 2025

Jan 23, 2025

bioAffinity Technologies (BIAF) Stock Price, News & Analysis - MarketBeat

Jan 23, 2025

Jan 22, 2025

BIOAFFINITY TECHNOLOGIES, INC. : Other Events, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Jan 22, 2025

Jan 22, 2025

bioAffinity Technologies secures Australian patent for ‘CyPath Lung’ spit test - Mugglehead

Jan 22, 2025

Jan 22, 2025

bioAffinity secures Australian patent for lung cancer test - MSN

Jan 22, 2025

Jan 22, 2025

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic - BioSpace

Jan 22, 2025

Jan 21, 2025

bioAffinity Technologies stock hits 52-week low at $0.65 - MSN

Jan 21, 2025

Jan 18, 2025

Biotech company CEO receives pay bump - San Antonio Business Journal

Jan 18, 2025

Jan 15, 2025

bioAffinity Technologies Increases CEO Maria Zannes’ Annual Base Salary to $300,000 - Defense World

Jan 15, 2025

Jan 14, 2025

bioAffinity Technologies Adjusts CEO Compensation Package - TipRanks

Jan 14, 2025

Jan 14, 2025

bioAffinity Technologies CEO receives salary increase - Investing.com

Jan 14, 2025

Jan 14, 2025

bioAffinity Technologies (NASDAQ:BIAFW) Trading Up 4.7% – Time to Buy? - Defense World

Jan 14, 2025

Jan 13, 2025

bioAffinity Technologies Reports Positive Results from Texas Beta Launch of CyPath® Lung - BioSpace

Jan 13, 2025

Jan 13, 2025

bioAffinity's Breakthrough Lung Cancer Test Shows 92% Accuracy, Could Save Medicare $379M - StockTitan

Jan 13, 2025

Jan 10, 2025

Enlivex CEO to Showcase Breakthrough Allocetra Cell Therapy on Bloomberg TV Special Feature - StockTitan

Jan 10, 2025

Dec 26, 2024

**bioAffinity Technologies Reports Results of 2024 Special Meeting** - Defense World

Dec 26, 2024

Dec 24, 2024

bioAffinity Technologies (NASDAQ:BIAF) Shares Down 2% – Here’s Why - Defense World

Dec 24, 2024

Dec 21, 2024

bioAffinity Technologies Boosts Sales with CyPath Lung - Yahoo Finance

Dec 21, 2024

Dec 21, 2024

bioAffinity Technologies (NASDAQ:BIAFW) Trading Down 25.7% – Time to Sell? - Defense World

Dec 21, 2024

Dec 20, 2024

San Antonio biotech company looks to expand in 2025 - The Business Journals

Dec 20, 2024